ID   NEK2_HUMAN              Reviewed;         445 AA.
AC   P51955; Q53FD6; Q5VXZ1; Q6NZX8; Q7Z634; Q86XH2; Q96QN9;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   05-OCT-2010, entry version 119.
DE   RecName: Full=Serine/threonine-protein kinase Nek2;
DE            EC=2.7.11.1;
DE   AltName: Full=HSPK 21;
DE   AltName: Full=Never in mitosis A-related kinase 2;
DE            Short=NimA-related protein kinase 2;
DE   AltName: Full=NimA-like protein kinase 1;
GN   Name=NEK2; Synonyms=NEK2A, NLK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Nasopharynx, Placenta, and T-cell;
RX   MEDLINE=94368699; PubMed=7522034;
RA   Schultz S.J., Fry A.M., Suetterlin C., Ried T., Nigg E.A.;
RT   "Cell cycle-dependent expression of Nek2, a novel human protein kinase
RT   related to the NIMA mitotic regulator of Aspergillus nidulans.";
RL   Cell Growth Differ. 5:625-635(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND
RP   DIMERIZATION.
RX   MEDLINE=21607591; PubMed=11742531; DOI=10.1042/0264-6021:3610077;
RA   Hames R.S., Fry A.M.;
RT   "Alternative splice variants of the human centrosome kinase Nek2
RT   exhibit distinct patterns of expression in mitosis.";
RL   Biochem. J. 361:77-85(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lu K.P., Hunter T.;
RT   "Molecular cloning and expression of NLK1, a human NIMA-like kinase.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-354.
RC   TISSUE=Testis;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Mammary gland, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 83-203.
RX   MEDLINE=94100173; PubMed=8274451;
RA   Schultz S.J., Nigg E.A.;
RT   "Identification of 21 novel human protein kinases, including 3 members
RT   of a family related to the cell cycle regulator nimA of Aspergillus
RT   nidulans.";
RL   Cell Growth Differ. 4:821-830(1993).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 305-445, FUNCTION, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH MAD1L1.
RX   PubMed=14978040; DOI=10.1074/jbc.M314205200;
RA   Lou Y., Yao J., Zereshki A., Dou Z., Ahmed K., Wang H., Hu J.,
RA   Wang Y., Yao X.;
RT   "NEK2A interacts with MAD1 and possibly functions as a novel
RT   integrator of the spindle checkpoint signaling.";
RL   J. Biol. Chem. 279:20049-20057(2004).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND MUTAGENESIS OF
RP   LYS-37.
RX   PubMed=15161910; DOI=10.1074/jbc.M404104200;
RA   Noguchi K., Fukazawa H., Murakami Y., Uehara Y.;
RT   "Nucleolar Nek11 is a novel target of Nek2A in G1/S-arrested cells.";
RL   J. Biol. Chem. 279:32716-32727(2004).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SGOL1.
RX   PubMed=17621308; DOI=10.1038/cr.2007.55;
RA   Fu G., Ding X., Yuan K., Aikhionbare F., Yao J., Cai X., Jiang K.,
RA   Yao X.;
RT   "Phosphorylation of human Sgo1 by NEK2A is essential for chromosome
RT   congression in mitosis.";
RL   Cell Res. 17:608-618(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184; SER-296 AND
RP   SER-300, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-299 AND
RP   SER-300, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-271 IN COMPLEX WITH
RP   INHIBITOR SU11652, PHOSPHORYLATION AT THR-170; SER-171; THR-175;
RP   THR-179; SER-241; SER-356; SER-387; SER-390; SER-397; SER-402 AND
RP   SER-428, MUTAGENESIS OF LYS-37; ASP-141; THR-170; SER-171; THR-175;
RP   THR-179 AND SER-241, AND MASS SPECTROMETRY.
RX   PubMed=17197699; DOI=10.1074/jbc.M609721200;
RA   Rellos P., Ivins F.J., Baxter J.E., Pike A., Nott T.J.,
RA   Parkinson D.M., Das S., Howell S., Fedorov O., Shen Q.Y., Fry A.M.,
RA   Knapp S., Smerdon S.J.;
RT   "Structure and regulation of the human Nek2 centrosomal kinase.";
RL   J. Biol. Chem. 282:6833-6842(2007).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-354 AND TYR-410.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase that is involved in mitotic regulation.
CC       Integral component of the mitotic spindle-assembly checkpoint
CC       which is necessary for proper chromosome segregation during
CC       metaphase-anaphase transition. Required for association of MAD2L1
CC       to kinetochore. Phosphorylates SGOL1. May have a role at the G2-M
CC       transition. May also play a role in meiosis. Isoform 1 but not
CC       isoform 2 appears to play a role in centrosome splitting. Isoform
CC       1 phosphorylates and activates NEK11 in G1/S-arrested cells.
CC       Isoform 2, which is not present in the nucleolus, does not.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Isoform 1 and isoform 2 form homo- and heterodimers.
CC       Interacts with TERF1, SGOL1 and MAD1L1.
CC   -!- INTERACTION:
CC       Q6GQ04:- (xeno); NbExp=2; IntAct=EBI-633182, EBI-995003;
CC       P30260:CDC27; NbExp=1; IntAct=EBI-633182, EBI-994813;
CC       Q8NG66:NEK11; NbExp=5; IntAct=EBI-633182, EBI-633195;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere (By
CC       similarity). Chromosome, centromere, kinetochore. Note=Co-
CC       localizes with SGOL1 and MAD1L1 at the kinetochore. Not associated
CC       with kinetochore in the interphase but becomes associated with it
CC       upon the breakdown of the nuclear envelope.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus, nucleolus. Note=Has a
CC       nucleolar targeting/ retention activity via a coiled-coil domain
CC       at the C-terminal end.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Note=Predominantly
CC       cytoplasmic.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=A;
CC         IsoId=P51955-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=P51955-2; Sequence=VSP_015578, VSP_015579;
CC       Name=3;
CC         IsoId=P51955-3; Sequence=VSP_015576, VSP_015577;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in
CC       peripheral blood T-cells and a wide variety of transformed cell
CC       types.
CC   -!- DEVELOPMENTAL STAGE: Accumulates throughout S phase and shows
CC       maximal levels in late G2. This expression pattern is highly
CC       reminiscent of that of A and B cyclins. Isoform 1 and isoform 2
CC       expression is low in the G1 phase and increases in the S/G2
CC       phases. Isoform 1 is absent from cells arrested in the G2/M
CC       prometaphase. Isoform 2 remains present in cells arrested in the
CC       G2/M prometaphase.
CC   -!- PTM: It is unsure whether Thr-170 or Ser-171 is phosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH65932.1; Type=Frameshift; Positions=213;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z29066; CAA82309.1; -; mRNA.
DR   EMBL; AY045701; AAK92212.1; -; mRNA.
DR   EMBL; U11050; AAA19558.1; -; mRNA.
DR   EMBL; BT019729; AAV38534.1; -; mRNA.
DR   EMBL; AK223353; BAD97073.1; -; mRNA.
DR   EMBL; AL356310; CAH72901.1; -; Genomic_DNA.
DR   EMBL; AC096637; CAH72901.1; JOINED; Genomic_DNA.
DR   EMBL; BC043502; AAH43502.2; -; mRNA.
DR   EMBL; BC052807; AAH52807.1; -; mRNA.
DR   EMBL; BC065932; AAH65932.1; ALT_FRAME; mRNA.
DR   EMBL; Z25425; CAA80912.1; -; mRNA.
DR   IPI; IPI00021331; -.
DR   IPI; IPI00641713; -.
DR   IPI; IPI00647904; -.
DR   PIR; G01452; G01452.
DR   PIR; I38215; I38215.
DR   RefSeq; NP_002488.1; -.
DR   UniGene; Hs.153704; -.
DR   PDB; 2JAV; X-ray; 2.20 A; A=1-271.
DR   PDB; 2W5A; X-ray; 1.55 A; A=1-271.
DR   PDB; 2W5B; X-ray; 2.40 A; A=1-271.
DR   PDB; 2W5H; X-ray; 2.33 A; A=1-271.
DR   PDB; 2WQO; X-ray; 2.17 A; A=1-271.
DR   PDBsum; 2JAV; -.
DR   PDBsum; 2W5A; -.
DR   PDBsum; 2W5B; -.
DR   PDBsum; 2W5H; -.
DR   PDBsum; 2WQO; -.
DR   ProteinModelPortal; P51955; -.
DR   IntAct; P51955; 21.
DR   STRING; P51955; -.
DR   PhosphoSite; P51955; -.
DR   PRIDE; P51955; -.
DR   Ensembl; ENST00000366999; ENSP00000355966; ENSG00000117650.
DR   GeneID; 4751; -.
DR   KEGG; hsa:4751; -.
DR   UCSC; uc001hir.1; human.
DR   UCSC; uc001his.2; human.
DR   CTD; 4751; -.
DR   GeneCards; GC01M211836; -.
DR   H-InvDB; HIX0023615; -.
DR   HGNC; HGNC:7745; NEK2.
DR   HPA; CAB017530; -.
DR   MIM; 604043; gene.
DR   PharmGKB; PA31546; -.
DR   eggNOG; prNOG07028; -.
DR   HOVERGEN; HBG006461; -.
DR   InParanoid; P51955; -.
DR   OMA; QELCVRE; -.
DR   OrthoDB; EOG97M4HR; -.
DR   PhylomeDB; P51955; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; foxm1pathway; FOXM1 transcription factor network.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   Reactome; REACT_8017; APC-Cdc20 mediated degradation of Nek2A.
DR   NextBio; 18310; -.
DR   PMAP-CutDB; P51955; -.
DR   ArrayExpress; P51955; -.
DR   Bgee; P51955; -.
DR   CleanEx; HS_NEK2; -.
DR   Genevestigator; P51955; -.
DR   GermOnline; ENSG00000117650; Homo sapiens.
DR   GO; GO:0005813; C:centrosome; TAS:ProtInc.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0051299; P:centrosome separation; IDA:UniProtKB.
DR   GO; GO:0007126; P:meiosis; IEA:UniProtKB-KW.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0007088; P:regulation of mitosis; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Centromere; Chromosome; Chromosome partition;
KW   Coiled coil; Complete proteome; Cytoplasm; Kinase; Kinetochore;
KW   Magnesium; Meiosis; Metal-binding; Mitosis; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    445       Serine/threonine-protein kinase Nek2.
FT                                /FTId=PRO_0000086421.
FT   DOMAIN        8    271       Protein kinase.
FT   NP_BIND      14     22       ATP (By similarity).
FT   REGION      329    445       Necessary for interaction with MAD1L1.
FT   COILED      303    362       Potential.
FT   COILED      406    430       Potential.
FT   ACT_SITE    141    141       Proton acceptor (By similarity).
FT   BINDING      37     37       ATP.
FT   MOD_RES     170    170       Phosphothreonine; by autocatalysis
FT                                (Probable).
FT   MOD_RES     171    171       Phosphoserine; by autocatalysis
FT                                (Probable).
FT   MOD_RES     175    175       Phosphothreonine; by autocatalysis.
FT   MOD_RES     179    179       Phosphothreonine; by autocatalysis.
FT   MOD_RES     184    184       Phosphoserine.
FT   MOD_RES     241    241       Phosphoserine; by autocatalysis.
FT   MOD_RES     296    296       Phosphoserine.
FT   MOD_RES     299    299       Phosphoserine.
FT   MOD_RES     300    300       Phosphoserine.
FT   MOD_RES     356    356       Phosphoserine.
FT   MOD_RES     387    387       Phosphoserine.
FT   MOD_RES     390    390       Phosphoserine.
FT   MOD_RES     397    397       Phosphoserine.
FT   MOD_RES     402    402       Phosphoserine.
FT   MOD_RES     428    428       Phosphoserine.
FT   VAR_SEQ     323    326       REER -> KKKK (in isoform 3).
FT                                /FTId=VSP_015576.
FT   VAR_SEQ     327    445       Missing (in isoform 3).
FT                                /FTId=VSP_015577.
FT   VAR_SEQ     371    384       ELLNLPSSVIKKKV -> GMRINLVNRSWCYK (in
FT                                isoform 2).
FT                                /FTId=VSP_015578.
FT   VAR_SEQ     385    445       Missing (in isoform 2).
FT                                /FTId=VSP_015579.
FT   VARIANT     354    354       N -> S (in dbSNP:rs2230489).
FT                                /FTId=VAR_019990.
FT   VARIANT     410    410       C -> Y (in dbSNP:rs56102977).
FT                                /FTId=VAR_040907.
FT   MUTAGEN      37     37       K->R: Loss of kinase activity and of
FT                                ability to activate NEK11.
FT   MUTAGEN     141    141       D->A: Loss of autophosphorylation.
FT   MUTAGEN     170    170       T->A: No effect on kinase activity.
FT   MUTAGEN     170    170       T->E: Kinase activity increased by two
FT                                fold.
FT   MUTAGEN     171    171       S->A: No effect on kinase activity.
FT   MUTAGEN     171    171       S->D: Kinase activity increased by two
FT                                fold.
FT   MUTAGEN     175    175       T->A: Kinase activity decreased by two
FT                                fold.
FT   MUTAGEN     175    175       T->E: Kinase activity increased by two
FT                                fold.
FT   MUTAGEN     179    179       T->A: Loss of kinase activity.
FT   MUTAGEN     179    179       T->E: Loss of kinase activity.
FT   MUTAGEN     241    241       S->A: Loss of kinase activity.
FT   MUTAGEN     241    241       S->D: Loss of kinase activity.
FT   CONFLICT     84     85       IV -> LY (in Ref. 8; CAA80912).
FT   CONFLICT    325    325       E -> K (in Ref. 5; BAD97073).
FT   HELIX         5      7
FT   STRAND        8     16
FT   STRAND       18     27
FT   TURN         28     30
FT   STRAND       33     39
FT   HELIX        46     58
FT   STRAND       70     75
FT   STRAND       82     87
FT   HELIX        94    104
FT   HELIX       110    130
FT   HELIX       144    146
FT   STRAND      147    149
FT   STRAND      155    157
FT   HELIX       160    165
FT   HELIX       185    188
FT   HELIX       195    211
FT   HELIX       221    230
FT   HELIX       242    251
FT   HELIX       256    258
FT   HELIX       262    266
SQ   SEQUENCE   445 AA;  51763 MW;  D33A37778ABB6D9E CRC64;
     MPSRAEDYEV LYTIGTGSYG RCQKIRRKSD GKILVWKELD YGSMTEAEKQ MLVSEVNLLR
     ELKHPNIVRY YDRIIDRTNT TLYIVMEYCE GGDLASVITK GTKERQYLDE EFVLRVMTQL
     TLALKECHRR SDGGHTVLHR DLKPANVFLD GKQNVKLGDF GLARILNHDT SFAKTFVGTP
     YYMSPEQMNR MSYNEKSDIW SLGCLLYELC ALMPPFTAFS QKELAGKIRE GKFRRIPYRY
     SDELNEIITR MLNLKDYHRP SVEEILENPL IADLVADEQR RNLERRGRQL GEPEKSQDSS
     PVLSELKLKE IQLQERERAL KAREERLEQK EQELCVRERL AEDKLARAEN LLKNYSLLKE
     RKFLSLASNP ELLNLPSSVI KKKVHFSGES KENIMRSENS ESQLTSKSKC KDLKKRLHAA
     QLRAQALSDI EKNYQLKSRQ ILGMR
//
